USD 21.0 billion in 2026 to USD 41.3 billion by 2036, expanding at a compound annual growth rate (CAGR) of 7.0%, according to Fact.MR.
Read MoreExplore the Digital PCR Market, including industry trends, growth opportunities, technological advancements, and key factors shaping market development.
Read MoreUSD 4.5 billion in 2026 to USD 17.8 billion by 2036, expanding at a compound annual growth rate (CAGR) of 14.9%, according to Fact.MR.
Read MoreUSD 17.0 billion in 2026 to USD 34.1 billion by 2036, registering a compound annual growth rate (CAGR) of 7.2%, according to Fact.MR.
Read MoreBuilding high-value strategic partnerships—including research collaborations, co-development deals, commercial co-promotion agreements, and CMO/CDMO supply alliances—is a core growth driver in life sciences. Key partner analysis systematically evaluates potential partner organizations based on technical capabilities, operational alignment, regional market access rights, financial health, and cultural compatibility. Conducting thorough partner evaluations enables biopharma developers and service providers to select optimal collaboration partners and structure long-term, mutually beneficial agreements.
Read More